New Briarane diterpenoids from the gorgonian coral Junceella juncea

Area of Science:

• Marine natural products chemistry
• Pharmacology

Background:

• Marine invertebrates, such as gorgonians, are a rich source of structurally diverse secondary metabolites.
• Junceella juncea, a type of gorgonian, has not been extensively studied for its chemical constituents.

Purpose of the Study:

• To isolate and characterize new briarane compounds from Junceella juncea.
• To evaluate the anti-inflammatory potential of the isolated compounds.

Main Methods:

• Chemical isolation techniques were employed to obtain pure compounds.
• Structural elucidation was performed using advanced spectroscopic methods, including 2D-Nuclear Magnetic Resonance (2D-NMR) and High-Resolution Mass Spectrometry (HRMS).
• In vitro assays were conducted to assess anti-inflammatory activity by measuring superoxide anion generation and elastase release in human neutrophils.

Main Results:

• Three new briarane compounds, named juncenolides M-O (1-3), were isolated.
• Compound 1 was identified as a novel chlorinated briarane.
• Compound 3 featured a rare methyl ester at the C-16 position.
• The anti-inflammatory effects were evaluated based on the modulation of neutrophil responses.

Conclusions:

• The chemical investigation of Junceella juncea yielded novel briarane derivatives.
• The identified compounds, particularly juncenolides M-O, represent new additions to the known briarane class.
• Further research into the anti-inflammatory mechanisms of these compounds is warranted.